Stock Comparison
REGN vs ROIV
Regeneron Pharmaceuticals Inc and Roivant Sciences Ltd side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$66.35B
$24.51B
P/E (TTM)
15.5
—
Forward P/E
14.1
—
Price/Sales
4.5
2,966.8
Price/Book
2.1
5.4
EV/EBITDA
10.5
0.7
Dividend Yield
0.58%
—
Profitability
Net Margin
29.60%
0.00%
Operating Margin
20.70%
-14675.00%
Return on Equity
14.50%
-7.59%
Return on Assets
6.13%
-14.30%
Growth (YoY)
Revenue Growth
19.00%
-66.70%
Earnings Growth
-7.20%
-96.10%
Price & Risk
Beta
0.2
1.1
52-Week High
$818.90
$34.68
52-Week Low
$516.07
$10.71
Analyst Target
$833.31
$39.04
Compare REGN and ROIV your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.